Scarica l'app Stockscreener
5.12
4.66%
-0.25
Dopo l'orario di chiusura:
5.09
-0.03
-0.59%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché SCYX Giù?
Forum
Previsione
Frazionamento azionario
Scynexis Inc Borsa (SCYX) Ultime notizie
Scynexis secures up to USD 214m in BARDA funding for antifungal SCY-247 - AllSci
Scynexis wins BARDA contract worth up to $214 million for antifungal SCY-247 - The Pharma Letter
Which USD 46 million antifungal biotech just won a government contract worth up to USD 214 million? - kalkine.ca
SCYNEXIS Secures BARDA Funding for Antifungal Pipeline - TipRanks
SCYNEXIS Inc. (SCYX) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
Scynexis stock surges on $214M BARDA contract for SCY-247 - Yahoo Finance
SCYX Stock Draws Trader Focus As New CFO And ADPKD Pivot Take Shape - timothysykes.com
SCYX Stock Draws Traders As Leadership And Kidney Pivot Advance - StocksToTrade
SCYNEXIS Wins BARDA Contract Worth Up to $214 Million for SCY-247 - citybiz
SCYNEXIS secures BARDA contract for antifungal development - Investing.com
Scynexis Shares Rise 13.9% After BARDA Awards SCY-247 Development Contract - Yahoo Finance
Why is Scynexis stock surging today? By Investing.com - Investing.com South Africa
A U.S. health agency could provide up to about $214 million to develop an antifungal treatment if all options are exercised. - Stock Titan
Stocktwits Pharma Pulse: Lilly, Novo Lead A Busy Week — Here Are The Stocks And Readouts To Watch - TradingView
SCYNEXIS, Inc. (SCYX) Stock Price, News, Quote & History - Yahoo! Finance Canada
SCYNEXIS, Inc. Announces Appointment of Steven K. Burke, M.D. to its Board of Directors, Effective September 18, 2026 - marketscreener.com
SCYNEXIS Appoints Nephrology Veteran Steven K. Burke to Board of Directors - Minichart
SCYNEXIS adds veteran biopharma leader to board - TipRanks
Scynexis appoints Steven Burke to board of directors - Investing.com
Scynexis (NASDAQ: SCYX) adds kidney drug specialist to its board - Stock Titan
SCYNEXIS Appoints Seasoned Industry Veteran Steven K. Burke, M.D., to its Board of Directors - The Manila Times
SCYNEXIS (Nasdaq:SCYX)Stock Analysis - Simply Wall Street
SCYNEXIS, Inc. (SCYX) Stock Price Prediction for 2026, 2030-2040 - Traders Union
Scynexis appoints Todd Minga as senior VP of R&D By Investing.com - Investing.com Australia
Scynexis appoints Todd Minga as senior VP of R&D - Investing.com
SCYNEXIS Appoints Todd Minga, M.D., as Senior Vice President, Research & Development - The Manila Times
A kidney specialist joins SCYNEXIS to lead rare-disease research - Stock Titan
SCYNEXIS Inc Extraordinary Shareholders Meeting Transcript - GuruFocus
SCYNEXIS at Cantor healthcare conference: rare-disease push takes shape By Investing.com - Investing.com South Africa
Scynexis (SCYX) awards CFO 100,000 stock options vesting over 4 years - Stock Titan
New Scynexis (SCYX) CFO reports no company shares - Stock Titan
SCYNEXIS INC (NASDAQ: SCYX) Appoints Sanjay Subramanian as CFO with $500,000 Annual Salary - Kalkine Media
SCYX: Phase II trial of SCY-770 for ADPKD to launch by year-end, targeting major unmet need - TradingView
SCYNEXIS at Cantor healthcare conference: rare-disease push takes shape - Investing.com
Scynexis names Sanjay Subramanian as chief financial officer - Investing.com
symbol__ Stock Quote Price and Forecast - CNN
Form 8K Scynexis Inc For: 10 September By Investing.com - Investing.com Nigeria
SCYNEXIS, Inc. Announces Executive Changes, Effective September 9, 2026 - marketscreener.com
SCYX Looks 72.0% Undervalued on GF Value™ but Remains a Possible Value Trap - GuruFocus
SCYNEXIS, Inc. Announces CFO Changes, Effective September 9, 2026 - marketscreener.com
SCYNEXIS Appoints Sanjay Subramanian CFO as Biotech Advances Rare Disease Pipeline - citybiz
SCYNEXIS Names Sanjay Subramanian as CFO - marketscreener.com
Scynexis names Sanjay Subramanian as chief financial officer By Investing.com - Investing.com India
SCYNEXIS appoints new CFO amid leadership transition - TipRanks
SCYNEXIS Announces Appointment of Sanjay Subramanian as Chief Financial Officer - The Manila Times
Scynexis Announces Appointment Of Sanjay Subramanian As Chief Financial Officer - TradingView
A new finance chief brings 20 years of experience to SCYNEXIS - Stock Titan
Scynexis Appoints New CFO Amid Transition - Intellectia AI
Scynexis Inc (SCYX) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
SCYNEXIS Inc. (SCYX) Advances 1.92% to $5.32 as Stock Holds Above Key $5.05 SupportDiamond Pattern - vinanet.vn
Scynexis Inc (SCYX) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
SCYNEXIS, Inc. (SCYX) latest stock news and headlines - Yahoo Finance Australia
SCYNEXIS to Participate in Upcoming Investor Conferences - The Manila Times
1.15%
5.19%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):